Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003

類似資料

• Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
  著者:: Lennard, Lynne, 等
  出版事項: (2014)
• Thiopurine methyltransferase genotype–phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia
  著者:: Lennard, Lynne, 等
  出版事項: (2013)
• Meta-analysis of randomized trials comparing thiopurines in childhood acute lymphoblastic leukaemia
  著者:: Escherich, Gabriele M, 等
  出版事項: (2011)
• Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.
  著者:: Lennard, L, 等
  出版事項: (1993)
• Thiopurine S-Methyltransferase Polymorphism in Iraqi Paediatric Patients with Acute Lymphoblastic Leukaemia
  著者:: NAWARS MOHAMMED, 等
  出版事項: (2019-01-01)